Substance / Medication

Gemifloxacin mesylate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
0
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Gemifloxacin mesylate (GFM): dissolution test based on in vivo data.
Paim Clésio Soldateli, Verlindo de Araújo Bibiana, Volpato Nádia Maria et al. · Drug Dev Ind Pharm · 2015
PMID: 24517572Observational
Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study.
Paim Clésio S, Führ Fernanda, Barth Aline B et al. · Talanta · 2011
PMID: 21238783Observational
Rapid elimination of antibiotic gemifloxacin mesylate and methylene blue over Pt nanoparticles dispersed chitosan/g-CNternary visible light photocatalyst.
Faisal Mohd, Ahmed Jahir, Jalalah Mohammed et al. · Environ Sci Pollut Res Int · 2023
PMID: 36933133Other
Structural elucidation of gemifloxacin mesylate degradation product.
Paim Clésio Soldateli, Führ Fernanda, Martins Magda Targa et al. · Biomed Chromatogr · 2016
PMID: 26205148Other
Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations.
Al-Tamimi Salma Ali, Alarfaj Nawal Ahmad, Aly Fatma Ahmed et al. · Luminescence · 2014
PMID: 23681953Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Gemifloxacin mesilate (substance)
SNOMED CT
426551002
UMLS CUI
C1321744

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

8
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.